Trulicity 1.5mg Injection

Trulicity 1.5 mg injection belongs to the class of anti-diabetic drugs primarily used to treat type 2 diabetes mellitus. Diabetes mellitus is a metabolic disease that causes high blood sugar levels. It occurs when the insulin (a hormone produced by the beta cells of the pancreas) is resistant in breaking the glucose to produce energy (insulin resistance) or the pancreas produces little or no insulin at all.Trulicity 1.5 mg injection contains Dulaglutide that belongs to the class of ‘incretin mimetics’. Dulaglutide works by increasing insulin release from the pancreas during high blood sugar levels (after meals) and decreasing the amount of sugar the liver makes. Trulicity 1.5 mg injection also prevents the risk of heart diseases in type 2 diabetes patients.

Treatment of Type 2 Diabetes mellitus

Trulicity 1.5 mg injection should be administered subcutaneously (under the skin) in the abdomen, thigh or upper arm. Your doctor or nurse will guide you on how to use the injection. Your doctor will prescribe the dosage based on your disease condition and tolerance. Your doctor may start the course with a low dose and gradually maintain an effective dose to achieve the required blood glucose control.

Trulicity 1.5mg Injection, a GLP-1 receptor agonist, improves glycemic control in individuals with type 2 diabetes by stimulating insulin secretion, suppressing glucagon release (a hormone that prevents excessive glucose production by the liver.), and slowing gastric emptying. These actions work together to lower blood sugar levels, promote weight loss or weight maintenance, and reduce appetite. By addressing multiple aspects of diabetes management, this medication offers a comprehensive therapeutic effect for individuals with type 2 diabetes.

COLD CHAIN

2 PREFILLED SYRINGE